Everything you need to know about Biogen’s (BIIB) Q1 2023 earnings
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the first quarter of 2023. Total revenue declined 3% year-over-year to $2.46 billion. For […]
The post Everything you need to know about Biogen’s (BIIB) Q1 2023 earnings first appeared on AlphaStreet.